Insider Trading Activity Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) – CFO Bought 10,000 shares of Stock

Insider Trading Activity For Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG)

Sarah Romano , CFO of Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) reportedly Bought 10,000 shares of the company’s stock at an average price of 1 for a total transaction amount of $10,000.00 SEC Form

Insider Trading History For Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG)

On 2/19/2015 Paul G Chaney, Director, bought 8,333 with an average share price of $6.00 per share and the total transaction amounting to $49,998.00.View SEC Filing

On 2/19/2015 (Innoven Partenaires S.A. Ipsa, Major Shareholder, bought 366,667 with an average share price of $6.00 per share and the total transaction amounting to $2,200,002.00.View SEC Filing

On 6/7/2016 Morton Goldberg, Director, sold 10,939 with an average share price of $3.31 per share and the total transaction amounting to $36,208.09.View SEC Filing

On 6/8/2016 Ventech Capital Ii, Major Shareholder, sold 29,400 with an average share price of $3.25 per share and the total transaction amounting to $95,550.00.View SEC Filing

On 6/10/2016 Ventech Capital Ii, Major Shareholder, sold 28,600 with an average share price of $3.04 per share and the total transaction amounting to $86,944.00.View SEC Filing

On 6/15/2016 Morton Goldberg, Director, sold 15,000 with an average share price of $3.16 per share and the total transaction amounting to $47,400.00.View SEC Filing

On 9/15/2016 Stephen From, Insider, bought 15,000 with an average share price of $1.49 per share and the total transaction amounting to $22,350.00.View SEC Filing

Analyst Ratings For Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG)
These are 4 Buy Ratings .
The current consensus rating for Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) is Buy (Score: 3.00) with a consensus target price of $7.33 , a potential (688.53% upside)

Analyst Ratings History For Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG)

• On 6/28/2016 Maxim Group Reiterated Rating Hold
• On 12/1/2016 Rodman & Renshaw Reiterated Rating Buy with a price target of $10.00
• On 12/6/2016 Chardan Capital Reiterated Rating Buy with a price target of $6.00
• On 5/19/2017 Noble Financial Reiterated Rating Buy
• On 8/8/2017 HC Wainwright Set Price Target of rating Buy with a price target of $6.00

Recent Trading Activity for Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG)
Shares of Eyegate Pharmaceuticals, Inc. closed the previous trading session at 0.930 down -0.020 -2.12% with 47,745 shares trading hands.